Product logins

Find logins to all Clarivate products below.


Trauma Devices | Medtech 360 | Market Insights | Asia Pacific | 2021

Compared to other major orthopedic markets, the Asia Pacific trauma device market will be somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Although trauma device market will be limited by pricing pressures and a challenging reimbursement environment and nationalist policies in China and India, once the market stabilizes, advancements in medical facilities and MNCs increasingly focusing on physician training will lead to overall trauma device market expansion through 2029.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will be supported by sustained demand for surgical revascularization in patients with increasingly complex CAD, where CABG remains the preferred treatment option…